Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul:81:44-55.
doi: 10.1016/j.jaut.2017.03.005. Epub 2017 Mar 23.

Inhibition of effector antigen-specific T cells by intradermal administration of heme oxygenase-1 inducers

Thomas Simon  1 , Julien Pogu  2 , Séverine Rémy  2 , Frédéric Brau  3 , Sylvie Pogu  4 , Maud Maquigneau  2 , Jean-François Fonteneau  5 , Nicolas Poirier  6 , Bernard Vanhove  2 , Gilles Blancho  2 , Eliane Piaggio  7 , Ignacio Anegon  2 , Philippe Blancou  8
Affiliations

Inhibition of effector antigen-specific T cells by intradermal administration of heme oxygenase-1 inducers

Thomas Simon et al. J Autoimmun. 2017 Jul.

Abstract

Developing protocols aimed at inhibiting effector T cells would be key for the treatment of T cell-dependent autoimmune diseases including type 1 autoimmune diabetes (T1D) and multiple sclerosis (MS). While heme oxygenase-1 (HO-1) inducers are clinically approved drugs for non-immune-related diseases, they do have immunosuppressive properties when administered systemically in rodents. Here we show that HO-1 inducers inhibit antigen-specific effector T cells when injected intradermally together with the T cell cognate antigens in mice. This phenomenon was observed in both a CD8+ T cell-mediated model of T1D and in a CD4+ T cell-dependent MS model. Intradermal injection of HO-1 inducers induced the recruitment of HO-1+ monocyte-derived dendritic cell (MoDCs) exclusively to the lymph nodes (LN) draining the site of intradermal injection. After encountering HO-1+MoDCs, effector T-cells exhibited a lower velocity and a reduced ability to migrate towards chemokine gradients resulting in impaired accumulation to the inflamed organ. Intradermal co-injection of a clinically approved HO-1 inducer and a specific antigen to non-human primates also induced HO-1+ MoDCs to accumulate in dermal draining LN and to suppress delayed-type hypersensitivity. Therefore, in both mice and non-human primates, HO-1 inducers delivered locally inhibited effector T-cells in an antigen-specific manner, paving the way for repositioning these drugs for the treatment of immune-mediated diseases.

Keywords: Auto-immune encephalomyelitis; Autoimmunity; Delayed type hypersensitivity; Diabetes; Heme oxygenase-1; Migration; Monocyte-derived dendritic cells; T-lymphocyte; Tolerance.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

MeSH terms

LinkOut - more resources